The Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes ® initiative to China and India, pledging $15 million over five years to help these developing nations with rapidly growing numbers of type 2 diabetes patients.
The International Diabetes Foundation (IDF) reports that more than 90 million people in China – 9.3 percent of the population – had type 2 diabetes in 2011, the most of any country. That figure is projected to grow to 129.7 million, or 12.1 percent of the population, by 2030.
India, which has 61.26 million people diagnosed with type 2 diabetes (8.3 percent of the population), ranks second only to China in total cases and third behind the United States (10.9 percent) and China in terms of prevalence. By 2030, India will have 101.2 million people with type 2 diabetes, IDF projects.
“In keeping with a long legacy of addressing global health issues through innovative and sustainable philanthropic programs, Bristol-Myers Squibb and the Bristol-Myers Squibb Foundation are pleased to expand our philanthropic work in type 2 diabetes to China and India, where the disease has become a significant public health concern,” said Lamberto Andreotti, chief executive officer, Bristol-Myers Squibb. “We look forward to working with the Shanghai Charity Foundation to improve the management of type 2 diabetes in Shanghai.”As part of today’s announcement, Together on Diabetes ® awarded the Shanghai Charity Foundation (SCF) a grant of US $522,797 over three years to create an efficient and effective community-based, block-by-block approach for managing type 2 diabetes in Shanghai, a mega-city of 23 million people. The most recent survey conducted by the Shanghai Center for Disease Control (SCDC) shows the prevalence of type 2 diabetes in Shanghai reached 16 percent last year, more than 6 percentage points above the national average and nearly 5 percentage points higher than other Chinese cities.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV